CG Oncology
cgoncology.com
Prescription Drugs
Health Care
Cell & Gene Therapy
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
CG Oncology is a late-stage pharmaceutical company that is passionate about developing and delivering bladder-sparing immunotherapies.
News
IBCN 2026 - BOND-003 Cohort C and Urinary Cytokines Poster
The post IBCN 2026 - BOND-003 Cohort C and Urinary Cytokines Poster appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
IBCN 2026 - BOND-003 Cohort C and Urinary Tumor DNA Podium
The post IBCN 2026 - BOND-003 Cohort C and Urinary Tumor DNA Podium appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
Bladder & Kidney Cancer Academy 2026 Podium
The post Bladder & Kidney Cancer Academy 2026 Podium appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
NSAUA 2026 - CORE-008 Cohort CX Topline Poster
The post NSAUA 2026 - CORE-008 Cohort CX Topline Poster appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
NSAUA 2026 - CORE-008 Cohort A and PK/PD Poster
The post NSAUA 2026 - CORE-008 Cohort A and PK/PD Poster appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
NSAUA 2026 - BOND-003 Cohort P Topline Poster
The post NSAUA 2026 - BOND-003 Cohort P Topline Poster appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
NSAUA 2026 - BOND-003 Cohort C Second Line Poster
The post NSAUA 2026 - BOND-003 Cohort C Second Line Poster appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
NSAUA 2026 - BOND-003 Cohort C and Cytokines Poster
The post NSAUA 2026 - BOND-003 Cohort C and Cytokines Poster appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
Albert Institute 2026 - Cretostimogene's Combination Potential
The post Albert Institute 2026 - Cretostimogene's Combination Potential appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
SCSAUA 2026 - CORE-008 Cohort A and PK/PD Insights Poster
The post SCSAUA 2026 - CORE-008 Cohort A and PK/PD Insights Poster appeared first on Bladder cancer Oncolytic immunotherapy cretostimogene grenadenorepvec CG Oncology - CG Oncology.
Read more
Report
Show more news